Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

2015 Drug Recalls: While FDA Drove Pharmacies, Quality Systems Drove Manufacturers

This article was originally published in The Gold Sheet

Executive Summary

Huge recall numbers last year reflected FDA's continued enforcement of sterility assurance at compounding pharmacies, while generic and brand manufacturers dealt with particulate contamination and various out-of-specification issues.

Advertisement

Related Content

FDA Warning Letter Slams Another Asian API Firm On Data Integrity
Contamination Issues Drove Drug Recalls to Record Levels in 2011

Topics

Advertisement
UsernamePublicRestriction

Register

PS000977

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel